Recent pharmacological advances in the repurposing of artemisinin drugs

Med Res Rev. 2021 Nov;41(6):3156-3181. doi: 10.1002/med.21837. Epub 2021 Jun 20.

Abstract

Artemisinins are a family of sesquiterpene lactones originally derived from the sweet wormwood (Artemisia annua). Beyond their well-characterized role as frontline antimalarial drugs, artemisinins have also received increased attention for other potential pharmaceutical effects, which include antiviral, antiparsitic, antifungal, anti-inflammatory, and anticancer activities. With concerted efforts in further preclinical and clinical studies, artemisinin-based drugs have the potential to be viable treatments for a great variety of human diseases. Here, we provide a comprehensive update on recent reports of pharmacological actions and applications of artemisinins outside of their better-known antimalarial role and highlight their potential therapeutic viability for various diseases.

Keywords: artemisinins; autoimmune disorder; cancer; infection; inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials* / pharmacology
  • Antimalarials* / therapeutic use
  • Artemisia annua*
  • Artemisinins* / pharmacology
  • Artemisinins* / therapeutic use
  • Drug Repositioning
  • Humans

Substances

  • Antimalarials
  • Artemisinins
  • artemisinin